APOE and early-onset autosomal dominant Alzheimer disease: Observational studies in healthy participants and Alzheimer’s disease patients have produced mixed results on the effect of DHA supplements on cognition and dementia risk, with no effects for any APOE genotype, beneficial effects only for APOE4 carriers, and only for APOE4 non-carriers all reported (Yassine et al., 2017a).